[10th International Conference on Behçet Syndrome. Berlin, June 27-29, 2002].
Weschler
B
B
Service de médecine IV, CHU Pitié-Salpêtrière, 83, boulevard de l'hôpital, 75651 Paris, France.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D001604:Berlin; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000069285:Infliximab; D000068800:Etanercept